{"database": "lobbying", "table": "lobbying_activities", "rows": [[1183076, "394cfc06-e026-4a47-b916-46374f23a82a", "4T", "STANTON PARK GROUP", 83717, "WATSON PHARMACEUTICALS", 2011, "fourth_quarter", "MMM", "Medicare and Medicaid reimbursement for pharmaceuticals.  Reimbursement for prostate cancer drugs.  Prevention of preterm birth.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 1, "2012-01-10T12:57:09-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1183076"], "units": {}, "query_ms": 0.3029170911759138, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}